DRKS00011293已完成未知

The influence of dietary supplements via calcium or sodium in attention to withdrawal symptoms, craving and relapse behavior in alcohol-dependent patients. - Ca2+

Zentralinstitut für Seelische GesundheitKlinik für Abhängiges Verhalten und Suchtmedizin0 个研究点目标入组 56 人开始时间: 2016年12月14日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•Inclusion Criteria are male and female alcohol-addicts, age: 18-70 years with diagnosis of alcohol dependence according to ICD-10 criteria.
•Because of frequently existing comorbid depressive symptoms, an existing depressive medication is limited to the drugs Sertralin (Zoloft®) und Remergil (Mirtazapin®).
•The ability to agreement after Fully Informed Consent and existing Written Informed Consent) is presupposed.

•- alcohol-addicts younger 18 years or older than 70 years
•- dependence of other substances (nicotine allowed)
•- drug treatment, which influences the results of the study, especially patients with intake of thiazide, tetracycline, sodium fluoride, bisphosphonates and corticosteroids
•- fatal physical sickness, especially of the calcium metabolism, operation of thyroid gland or parathyroid and kidney or adrenal sickness
•- fatal hypertonia or increased cardiovascular risk profile
•- female: pregnancy (with pregnancy test)
•- intake of anti-craving drugs
•- anti-craving drugs shoud be settled out prior two weeks
•- suicidal tendency or degree of competition from outside suppliers

发起方

Zentralinstitut für Seelische GesundheitKlinik für Abhängiges Verhalten und Suchtmedizin